Veritas will present two pioneering studies at the European Society of Human Genetics Conference, in Berlin from June 1 to June 4 . With a focus on elective genomic screening and newborn genomic screening, Veritas aims to set new standards in preventive medicine. The Conference, now in its 57th edition, is the largest scientific and professional event in human genetics, bringing together leading European and international experts in genetics, technology, and biomedicine.
MADRID , May 29, 2024 /PRNewswire/ -- Veritas will have a prominent presence at the upcoming European Society of Human Genetics (ESHG) Congress 2024, to be held in Berlin from June 1 to 4 . This year, Veritas will present two innovative studies, reaffirming its commitment to preventive medicine and genomic screening. Additionally, it will highlight its polygenic risk service, myHealthScore, which assesses the genetic risk of common diseases in adults.
The ESHG Congress 2024 is not only a platform for disseminating the most relevant advances in human genetics but also a space for education and knowledge exchange. Plenary sessions, symposia, workshops, and poster presentations will complete an exciting program that covers the latest developments in genetic science. In this 57th edition of ESHG, Veritas will showcase its comprehensive portfolio in preventive medicine and will participate with a booth (number 240) where its latest advances and services will be exhibited.
Innovative Studies Veritas will present tw.
